Showing results (1841-1850 of 3,095) with videos related to

Sort By:
Pageof 310
Clinical Kidney Journal|July 5, 2021
Predicting mortality in hemodialysis patients using machine learning analysisVictoria Garcia-Montemayor, Alejandro Martin-Malo, Carlo Barbieri, et al.
Clinical Kidney Journal|July 5, 2021
Effects of canagliflozin on serum potassium in the CANagliflozin cardioVascular Assessment Study (CANVAS) ProgramMatthew R Weir, April Slee, Tao Sun, et al.
Clinical Kidney Journal|July 5, 2021
Reverse pseudohyperkalemia is more than leukocytosis: a retrospective studyOsama El Shamy, Joshua L Rein, Siddhartha Kattamanchi, et al.
Clinical Kidney Journal|July 5, 2021
The effects of extracellular volume and intradialytic peripheral resistance changes on ambulatory blood pressure in hemodialysis patients with and without recurrent intradialytic hypertensionMeredith McAdams, L Parker Gregg, Rong Lu, et al.
Clinical Kidney Journal|July 5, 2021
Reversibility of oxalate nephropathy in a kidney transplant recipient with prior gastric bypass surgeryChristian Goul Sørensen, Christian Lodberg Hvas, Ingrid Møller Thomsen, et al.
Clinical Kidney Journal|July 5, 2021
Serum uromodulin is inversely associated with biomarkers of subclinical inflammation in the population-based KORA F4 studyCornelia Then, Christian Herder, Holger Then, et al.
Clinical Kidney Journal|July 5, 2021
A randomized phase 1b cross-over study of the safety of low-dose pioglitazone for treatment of autosomal dominant polycystic kidney diseaseBonnie L Blazer-Yost, Robert L Bacallao, Bradley J Erickson, et al.
Clinical Kidney Journal|July 5, 2021
Hyperkalemia excursions are associated with an increased risk of mortality and hospitalizations in hemodialysis patientsAngelo Karaboyas, Bruce M Robinson, Glen James, et al.
Clinical Kidney Journal|July 5, 2021
Pro-calcifying analysis of uraemic serum from patients treated with medium cut-off membrane in a prospective, cross-over studyPaola Ciceri, Giorgia Tettamanti, Andrea Galassi, et al.
Clinical Kidney Journal|July 5, 2021
Founding mutations explains hotspots of polycystic kidney disease in Southern SpainCarmen García Rabaneda, Francisco Perea, María Luz Bellido Díaz, et al.
Pageof 310